Analytical Data
-
Gene name
Aspdh
- Application
-
Alternative Names
Aspartate dehydrogenase domain-containing protein
-
Species
Mouse
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9DCQ2
-
Expression Region
1-287aa
-
Molecular Weight
37.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Aspartate racemase (AspDH) is an enzyme that plays a crucial role in the biosynthesis of L-aspartate and D-aspartate, amino acids that are important in various biological processes, including neurotransmission and cellular signaling. The study of AspDH has gained attention due to its potential implications in neurobiology and its role in certain neurological disorders. Understanding the function and structure of this enzyme could provide insights into the regulation of aspartate levels in the brain, as imbalances may be linked to conditions such as schizophrenia and other mental health disorders. Moreover, AspDH has been identified as a potential target for antimicrobial drug development, as certain pathogens rely on the racemization of aspartate for their survival. Recent advancements in recombinant protein technology have enabled researchers to produce AspDH in a controlled laboratory setting, allowing for detailed biochemical studies. These investigations include exploring its catalytic mechanism, substrate specificity, and structural conformations, which are essential for identifying inhibitors that could modulate its activity. As research progresses, the recombinant AspDH could serve as a valuable tool for both fundamental studies of amino acid metabolism and the development of therapeutic agents aimed at modifying its enzymatic function in various biological contexts. These efforts highlight the importance of AspDH in both basic science and potential clinical applications, making it a significant focus of contemporary biochemical research.
